Moderna stands to earn $300M for quick vaccine approval, up to $6.6B for extra doses: filing esagonowsky Mon, 08/17/2020 – 15:31 More: Moderna stands to earn 0M for quick vaccine approval, up to .6B for extra doses: filing Source: fierce
read moreComing COVID-19 vaccination wave will generate $20B in sales next year: analyst esagonowsky Mon, 08/17/2020 – 11:22 More: Coming COVID-19 vaccination wave will generate B in sales next year: analyst Source: fierce
read moreMcKesson signs up with Warp Speed to distribute COVID-19 shots in U.S. kblankenship Mon, 08/17/2020 – 10:40 More: McKesson signs up with Warp Speed to distribute COVID-19 shots in U.S. Source: fierce
read moreChinese regulators pen requirements for COVID-19 vaccine approval—and they’re stricter than the FDA’s aliu Mon, 08/17/2020 – 10:38 More: Chinese regulators pen requirements for COVID-19 vaccine approval—and they're stricter than the FDA's Source: fierce
read moreFiercePharmaPolitics—After hydroxychloroquine, Trump sets sights on another unproven COVID-19 treatment: report esagonowsky Mon, 08/17/2020 – 09:26 More: FiercePharmaPolitics—After hydroxychloroquine, Trump sets sights on another unproven COVID-19 treatment: report Source: fierce
read moreThe move bolsters the French drug giant’s core R&D areas of autoimmune and allergic diseases More: Sanofi buys Principia Biopharma Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals